https://www.selleckchem.com/products/ew-7197.html
Intravenous and p.o. formulations of class IC antiarrhythmics (flecainide more so than propafenone) are superior regarding conversion rates within 12h, while amiodarone efficacy is exhibited in a delayed fashion (within 24h), especially if ranolazine is added. Our network meta-analysis identified with sufficient power and consistency the most effective antiarrhythmics for pharmacologic cardioversion over different time settings, with vernakalant and flecainide exhibiting a safer and more efficacious profile toward faster cardioversion.